Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro
- PMID: 3132891
- DOI: 10.1002/ana.410230405
Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro
Abstract
Recombinant human tumor necrosis factor (rhTNF) has been tested for its effect on myelinated cultures of mouse spinal cord tissue. As controls, recombinant human interferon gamma (rhIFN) and interleukin-2 (rhIL-2) were tested, as well as T-cell supernatants, antigalactocerebroside serum, and normal culture medium. It was found that rhTNF induced delayed-onset (18-24 hr) oligodendrocyte necrosis and a type of myelin dilatation peculiar to this system. Some nerve fibers progressed to demyelination by 72 hours. The myelin dilatation was not reversible by return to normal feeding solution for 3 days. In contrast, rhIFN, rhIL-2, T-cell supernatants, and normal medium had little or no effect on cultures. This mechanism differs from other immune-mediated mechanisms in that it appears that a physiological (not structural) demyelination occurs initially without overt destruction of the myelin sheath. These observations are relevant to the evolution of the multiple sclerosis plaque: dysfunction of ionic channels might contribute to the eventual demise of oligodendrocytes and axons in the longstanding lesion.
Similar articles
-
Effects of interferon-gamma and tumor necrosis factor-alpha on survival and differentiation of oligodendrocyte progenitors.J Soc Gynecol Investig. 2004 Feb;11(2):89-96. doi: 10.1016/j.jsgi.2003.08.004. J Soc Gynecol Investig. 2004. PMID: 14980310
-
Antiserum-induced dissociation of myelinogenesis in vitro. An ultrastructural study.Lab Invest. 1978 Apr;38(4):397-403. Lab Invest. 1978. PMID: 642450
-
Endogenous leukemia inhibitory factor production limits autoimmune demyelination and oligodendrocyte loss.Glia. 2006 May;53(7):696-703. doi: 10.1002/glia.20321. Glia. 2006. PMID: 16498619
-
Some factors influencing the proliferation and differentiation of myelin-forming cells.Neurology. 1978 Sep;28(9 Pt 2):59-67. doi: 10.1212/wnl.28.9_part_2.59. Neurology. 1978. PMID: 362236 Review.
-
The reactions of the oligodendrocyte.Mult Scler. 1996 Dec;2(5):241-3. doi: 10.1177/135245859600200507. Mult Scler. 1996. PMID: 9050363 Review. No abstract available.
Cited by
-
Tumor necrosis factor production in patients with leprosy.Infect Immun. 1992 Apr;60(4):1441-6. doi: 10.1128/iai.60.4.1441-1446.1992. Infect Immun. 1992. PMID: 1548069 Free PMC article.
-
Protandim Protects Oligodendrocytes against an Oxidative Insult.Antioxidants (Basel). 2016 Sep 7;5(3):30. doi: 10.3390/antiox5030030. Antioxidants (Basel). 2016. PMID: 27618111 Free PMC article.
-
Demyelination, and remyelination by Schwann cells and oligodendrocytes after kainate-induced neuronal depletion in the central nervous system.Neuroscience. 1992 Nov;51(1):137-48. doi: 10.1016/0306-4522(92)90478-k. Neuroscience. 1992. PMID: 1465177 Free PMC article.
-
HIV in the CNS: pathogenic relationships to systemic HIV disease and other CNS diseases.J Neurovirol. 2001 Apr;7(2):85-96. doi: 10.1080/13550280152058744. J Neurovirol. 2001. PMID: 11517381 Review.
-
IFNgamma enhances microglial reactions to hippocampal axonal degeneration.J Neurosci. 2000 May 15;20(10):3612-21. doi: 10.1523/JNEUROSCI.20-10-03612.2000. J Neurosci. 2000. PMID: 10804203 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials